Gabapentin and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is found among people who take Gabapentin, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Gabapentin and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 264,649 people who have side effects when taking Gabapentin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
264,649 people reported to have side effects when taking Gabapentin.
Among them, 89 people (0.03%) have Paranasal sinus hypersecretion.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 273,137 Gabapentin users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 729 drugs and 393 conditions by eHealthMe.
Number of Gabapentin and Paranasal sinus hypersecretion reports submitted per year:
Time on Gabapentin when people have Paranasal sinus hypersecretion *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Paranasal sinus hypersecretion when taking Gabapentin *:
- female: 71.6 %
- male: 28.4 %
Age of people who have Paranasal sinus hypersecretion when taking Gabapentin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 14.29 %
- 20-29: 0.0 %
- 30-39: 5.36 %
- 40-49: 8.93 %
- 50-59: 17.86 %
- 60+: 53.57 %
Common drugs people take besides Gabapentin *:
- Synthroid: 13 people, 14.61%
- Breo Ellipta: 12 people, 13.48%
- Calcium: 12 people, 13.48%
- Humira: 10 people, 11.24%
- Vitamin D: 8 people, 8.99%
- Vitamin D3: 8 people, 8.99%
- Xyrem: 7 people, 7.87%
- Nexium: 7 people, 7.87%
- Metformin: 7 people, 7.87%
- Revlimid: 6 people, 6.74%
Common side effects people have besides Paranasal sinus hypersecretion *:
- Cough: 34 people, 38.20%
- Breathing Difficulty: 24 people, 26.97%
- Weight Decreased: 23 people, 25.84%
- Nausea (feeling of having an urge to vomit): 20 people, 22.47%
- Asthma: 18 people, 20.22%
- Chest Pain: 18 people, 20.22%
- Neuropathy Peripheral (surface nerve damage): 15 people, 16.85%
- Fatigue (feeling of tiredness): 15 people, 16.85%
- Pulmonary Mass: 15 people, 16.85%
- Sinus Disorder (disease of sinus): 15 people, 16.85%
Common conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 13.48%
- Depression: 8 people, 8.99%
- High Blood Pressure: 8 people, 8.99%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.87%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 7.87%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 7.87%
- Multiple Myeloma (cancer of the plasma cells): 6 people, 6.74%
- High Blood Cholesterol: 6 people, 6.74%
- Hypersensitivity: 5 people, 5.62%
- Stress And Anxiety: 5 people, 5.62%
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of gabapentin:
Alternative drugs to, pros and cons of Gabapentin:
- Gabapentin (273,137 reports)
Common Gabapentin side effects:
Browse all side effects of Gabapentin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (4,043 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (729 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (393 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Velcade and Carpine drug interaction - 2 seconds ago
- Insomnia and Prostatitis - 6 seconds ago
- Ischaemic Stroke and drugs of ingredients of sodium chloride - 7 seconds ago
- Valium and Cyclocort drug interaction - 18 seconds ago
- Glucosamine Sulfate and Requip drug interaction - 26 seconds ago
- Unasyn and Prevacid drug interaction - 41 seconds ago
- Zide and Vimovo drug interaction - 42 seconds ago
- Keloids and High Blood Pressure - 54 seconds ago
- Biaxin Xl and Metolazone drug interaction - 56 seconds ago
- Methotrexate and Metastases To Spine - a minute ago